These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 11896611
1. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, Takagi H, Mori M. Oncogene; 2002 Mar 14; 21(12):1791-9. PubMed ID: 11896611 [Abstract] [Full Text] [Related]
2. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Bell A, Chen Q, DeFrances MC, Michalopoulos GK, Zarnegar R. Oncogene; 1999 Jan 28; 18(4):887-95. PubMed ID: 10023664 [Abstract] [Full Text] [Related]
3. Hepatocyte growth factor promotes lung carcinogenesis in transgenic mice treated with diethylnitrosamine. Kojima A, Horiguchi N, Kakizaki S, Takayama H, Mori M. Anticancer Res; 2013 Mar 28; 33(3):895-901. PubMed ID: 23482759 [Abstract] [Full Text] [Related]
4. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis. Huang X, Yu C, Jin C, Kobayashi M, Bowles CA, Wang F, McKeehan WL. Cancer Res; 2006 Feb 01; 66(3):1481-90. PubMed ID: 16452204 [Abstract] [Full Text] [Related]
5. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M. Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539 [Abstract] [Full Text] [Related]
6. Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice. Shiota G, Kawasaki H, Nakamura T, Schmidt EV. Res Commun Mol Pathol Pharmacol; 1996 Jan 01; 91(1):33-9. PubMed ID: 8824929 [Abstract] [Full Text] [Related]
7. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice. Yau TO, Chan CF, Gee-San Lam S, Cheung OF, Ching YP, Jin DY, Sham MH, Ng IO. J Pathol; 2009 Feb 01; 217(3):353-61. PubMed ID: 19090486 [Abstract] [Full Text] [Related]
8. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model. Yu Y, Merlino G. Cancer Res; 2002 May 15; 62(10):2951-6. PubMed ID: 12019177 [Abstract] [Full Text] [Related]
9. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. Burr AW, Hillan KJ, McLaughlin KE, Ferrier R, Chapman C, Mathew J, Burt AD. Hepatology; 1996 Nov 15; 24(5):1282-7. PubMed ID: 8903411 [Abstract] [Full Text] [Related]
10. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Recio JA, Merlino G. Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907 [Abstract] [Full Text] [Related]
11. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH. Hepatology; 2002 Nov 01; 36(5):1089-97. PubMed ID: 12395318 [Abstract] [Full Text] [Related]
12. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Factor VM, Kao CY, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS. Cancer Res; 1997 Jun 01; 57(11):2089-95. PubMed ID: 9187100 [Abstract] [Full Text] [Related]
13. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Colombo ES, Menicucci G, McGuire PG, Das A. Invest Ophthalmol Vis Sci; 2007 Apr 01; 48(4):1793-800. PubMed ID: 17389513 [Abstract] [Full Text] [Related]
14. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y. Diabetologia; 2003 Jan 01; 46(1):115-23. PubMed ID: 12637990 [Abstract] [Full Text] [Related]
15. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells. To C, Seiden I, Liu N, Wigle D, Tsao MS. Exp Cell Res; 2002 Feb 01; 273(1):45-53. PubMed ID: 11795945 [Abstract] [Full Text] [Related]
16. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. Su W, Gutmann DH, Perry A, Abounader R, Laterra J, Sherman LS. Glia; 2004 Feb 01; 45(3):297-306. PubMed ID: 14730703 [Abstract] [Full Text] [Related]
17. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors. Naim R, Tolnay E, Mueller KM, Kuhnen C. Int J Mol Med; 2004 Nov 01; 14(5):787-91. PubMed ID: 15492846 [Abstract] [Full Text] [Related]
18. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH. Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653 [Abstract] [Full Text] [Related]
19. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G. Cancer Res; 1998 Nov 15; 58(22):5157-67. PubMed ID: 9823327 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Am J Pathol; 2000 Apr 15; 156(4):1337-44. PubMed ID: 10751359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]